HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

B Hundsdorfer Selected Research

Plasminogen Inactivators

5/2004[The prognostic importance of urinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in the primary resection of oral squamous cell carcinoma].
5/2004[Comparison of urokinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in primary resection of oral squamous cell carcinoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


B Hundsdorfer Research Topics

Disease

2Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2004 - 05/2004
1Residual Neoplasm
05/2004
1Neoplasms (Cancer)
05/2004

Drug/Important Bio-Agent (IBA)

2Plasminogen InactivatorsIBA
05/2004 - 05/2004
2Plasminogen Activators (Plasminogen Activator)IBA
05/2004 - 05/2004
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
05/2004
1Plasminogen Activator Inhibitor 1IBA
05/2004
1Peptide Hydrolases (Proteases)IBA
05/2004